Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection?

被引：21
|
作者：
Mullens, Wilfried
Martens, Pieter
机构：
[1] Ziekenhuis Oost Limburg, Genk, Belgium
[2] Univ Hasselt, Biomed Res Inst, Fac Med & Life Sci, Hasselt, Belgium
来源：
JACC-HEART FAILURE | 2021年 / 9卷 / 08期
关键词：
CMR; epicardial adipose tissue; heart failure; myocardial fibrosis; SGLT2-inhibitors;
D O I：
10.1016/j.jchf.2021.05.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：590 / 593
页数：4
相关论文
共 50 条
  • [31] The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator
    Roopameera Thirumathyam
    Erik Arne Richter
    Gerrit van Hall
    Jens Juul Holst
    Mogens Fenger
    Jens P. Gøtze
    Ulrik Dixen
    Niels Vejlstrup
    Sten Madsbad
    Per Lav Madsen
    Nils Bruun Jørgensen
    Cardiovascular Diabetology, 23
  • [32] Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer
    Sezer, Havva
    Yazici, Dilek
    Deyneli, Oguzhan
    Mericoz, Cisel
    Esin, Ayla
    Alper, Emrah
    ENDOKRYNOLOGIA POLSKA, 2020, 71 (03) : 283 - 284
  • [33] The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator
    Thirumathyam, Roopameera
    Richter, Erik Arne
    van Hall, Gerrit
    Holst, Jens Juul
    Fenger, Mogens
    Gotze, Jens P.
    Dixen, Ulrik
    Vejlstrup, Niels
    Madsbad, Sten
    Madsen, Per Lav
    Jorgensen, Nils Bruun
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [34] Changes in myocardial fluid filtration are reflected in epicardial lymph pressure
    VanTeeffelen, JWGE
    Merkus, D
    Vergroesen, I
    Spaan, JAE
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H706 - H713
  • [35] Increased myocardial dysfunction, dyssynchrony, and epicardial fat across the lifespan in healthy males
    Crendal, Edward
    Dutheil, Fred
    Naughton, Geraldine
    McDonald, Tracey
    Obert, Philippe
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [36] Increased myocardial dysfunction, dyssynchrony, and epicardial fat across the lifespan in healthy males
    Edward Crendal
    Fred Dutheil
    Geraldine Naughton
    Tracey McDonald
    Philippe Obert
    BMC Cardiovascular Disorders, 14
  • [37] The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts
    Corradi, D
    Maestri, R
    Callegari, S
    Pastori, P
    Goldoni, M
    Luong, TV
    Bordi, C
    CARDIOVASCULAR PATHOLOGY, 2004, 13 (06) : 313 - 316
  • [38] ISOPOTENTIAL EPICARDIAL CARTOGRAPHY OF EXPERIMENTALLY INDUCED ACUTE MYOCARDIAL ISCHEMIA
    PAGNY, JY
    PERRY, JB
    DARGIS, C
    GULRAJANI, R
    ROBERGE, F
    SESTIER, F
    UNION MEDICALE DU CANADA, 1980, 109 (10): : 1526 - 1526
  • [39] Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
    Gaborit, B.
    Ancel, P.
    Abdullah, A. E.
    Maurice, F.
    Abdesselam, I.
    Calen, A.
    Soghomonian, A.
    Houssays, M.
    Varlet, I.
    Eisinger, M.
    Lasbleiz, A.
    Peiretti, F.
    Bornet, C. E.
    Lefur, Y.
    Pini, L.
    Rapacchi, S.
    Bernard, M.
    Resseguier, N.
    Darmon, P.
    Kober, F.
    Dutour, A.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [40] Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
    B. Gaborit
    P. Ancel
    A. E. Abdullah
    F. Maurice
    I. Abdesselam
    A. Calen
    A. Soghomonian
    M. Houssays
    I. Varlet
    M. Eisinger
    A. Lasbleiz
    F. Peiretti
    C. E. Bornet
    Y. Lefur
    L. Pini
    S. Rapacchi
    M. Bernard
    N. Resseguier
    P. Darmon
    F. Kober
    A. Dutour
    Cardiovascular Diabetology, 20
12345